FDx Advisors Inc. Buys New Shares in Cardinal Health, Inc. $CAH

FDx Advisors Inc. purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,513 shares of the company’s stock, valued at approximately $254,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. increased its stake in shares of Cardinal Health by 25.0% during the 1st quarter. Stratos Wealth Partners LTD. now owns 7,588 shares of the company’s stock worth $1,046,000 after purchasing an additional 1,519 shares during the last quarter. Allworth Financial LP grew its holdings in Cardinal Health by 5.5% during the first quarter. Allworth Financial LP now owns 3,978 shares of the company’s stock worth $540,000 after purchasing an additional 207 shares during the period. Ballentine Partners LLC increased its position in Cardinal Health by 66.7% during the first quarter. Ballentine Partners LLC now owns 6,145 shares of the company’s stock worth $847,000 after buying an additional 2,459 shares during the last quarter. New York State Common Retirement Fund raised its stake in Cardinal Health by 2.2% in the first quarter. New York State Common Retirement Fund now owns 331,748 shares of the company’s stock valued at $45,705,000 after buying an additional 7,072 shares during the period. Finally, Stephens Inc. AR lifted its position in shares of Cardinal Health by 5.6% in the first quarter. Stephens Inc. AR now owns 6,195 shares of the company’s stock valued at $853,000 after buying an additional 329 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Argus increased their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the stock a “buy” rating in a report on Monday, November 3rd. Finally, UBS Group increased their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $205.00.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the sale, the chief executive officer owned 235,901 shares of the company’s stock, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last three months. Insiders own 0.12% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $203.40 on Monday. The firm has a market cap of $48.33 billion, a P/E ratio of 31.53, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The business’s fifty day moving average is $160.02 and its 200-day moving average is $156.87. Cardinal Health, Inc. has a 52-week low of $114.60 and a 52-week high of $203.67.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.